About Market Research Report Store Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests. Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.
Capricor Therapeutics, Inc. (CAPR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile ID: 269387 December 2016 Region: United States 25 pages GlobalData Single User License - $250.00 Corporate Users License - $500.00
Enterprise Wide License - $750.00
MRRS adds "Capricor Therapeutics, Inc. (CAPR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile" latest studies, published in December 2016. It is a professional and in-depth study.
Summary Capricor Therapeutics, Inc. (Capricor) is a biotechnology company that discovers, develops and commercializes therapeutics for various diseases. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced heart failure and duchenne muscular dystrophy associated cardiomyopathy. It offers CAP, cendertide and exosome products. Capricor conducts research and development on its exosomes platform technology. The company offers development for the outpatient treatment of heart failure and potential other indications. It offers research programs on cell therapy, natriuretic peptides and exosome platforms. Capricor is headquartered in Beverly Hills, California, the US. Capricor Therapeutics, Inc. (CAPR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope – Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. – Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. – Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. – Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. – Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector. – Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations. – Key Employees – A list of the key executives of the company. – Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company. – Key Competitors – A list of the key competitors of the company. – Key Recent Developments – A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements – The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period. Understand the company’s business segments’ expansion / divestiture strategy – The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy. Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company – Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios. Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. – The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company – Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research – Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents Table of Contents 2 List of Tables 3
List of Figures 4 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 10 Asset Purchase 10 Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 10 Venture Financing 12 Capricor Therapeutics Raises Funds through Venture Financing 12 Capricor Raises US$4.5 Million In Venture Financing 13 Capricor Raises US$2 Million In Venture Financing 14 Partnerships 15 Capricor Enters Into Co-Development Agreement With Janssen For Cell Therapy For Cardiovascular Applications 15 Licensing Agreements 16 Capricor Therapeutics Enters Into Licensing Agreement With Cedars-Sinai Medical 16 Equity Offering 17 Capricor Therapeutics to Raise USD4 Million in Private Placement of Shares and Warrants 17 Capricor Therapeutics to Raise USD7 Million in Private Placement of Shares 19 Acquisition 21 Nile Therapeutics Completes Acquisition Of Capricor In Reverse Takeover Transaction 21 Capricor Therapeutics, Inc. - Key Competitors 22 Key Employees 23 Locations And Subsidiaries 24 Head Office 24 Other Locations & Subsidiaries 24 Appendix 25 Methodology 25 About GlobalData 25
Contact Us 25 Disclaimer 25
List of Tables Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Capricor Therapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9 Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 10 Capricor Therapeutics Raises Funds through Venture Financing 12 Capricor Raises US$4.5 Million In Venture Financing 13 Capricor Raises US$2 Million In Venture Financing 14 Capricor Enters Into Co-Development Agreement With Janssen For Cell Therapy For Cardiovascular Applications 15 Capricor Therapeutics Enters Into Licensing Agreement With Cedars-Sinai Medical 16 Capricor Therapeutics to Raise USD4 Million in Private Placement of Shares and Warrants 17 Capricor Therapeutics to Raise USD7 Million in Private Placement of Shares 19 Nile Therapeutics Completes Acquisition Of Capricor In Reverse Takeover Transaction 21 Capricor Therapeutics, Inc., Key Competitors 22 Capricor Therapeutics, Inc., Key Employees 23 Capricor Therapeutics, Inc., Subsidiaries 24
List of Figures Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Capricor Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ask a sample and any further questions, please feel free to contact us: Tel: +00-1-626-3463946 - U.S Email: shirley@marketresearchreportstore.com Web: http://www.marketresearchreportstore.com/